SANA Q1 2021 Earnings — Sana Biotechnology, Inc. Revenue & Financial Results | Market Cap Arena

SANASana Biotechnology, Inc.

$900M

Q1 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$181M

Net Income

-$181M

EPS (Diluted)

$-0.99

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$50M

Free Cash Flow

-$56M

Stock-Based Comp.

$4M

Balance Sheet

Total Assets

$1.3B

Total Liabilities

$422M

Stockholders' Equity

$882M

Cash & Equivalents

$751M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	$0	—
Operating Income	-$181M	-$33M	-443.2%
Net Income	-$181M	-$33M	-449.4%